BRIGHTSURF

Could this molecule be “checkmate” for coronaviruses like SARS- CoV-2?

04.23.25 | University of California - San Francisco

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

This release has been removed upon request of the submitting institution because it is a duplicate of an existing release. Please find the link here to the release: https://www.eurekalert.org/news-releases/1081239 Please contact Levi Gadye, levi.gadye@ucsf.edu for more information.

Science Advances

10.1126/sciadv.adt7836

Experimental study

Cells

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus- MPro inhibitors with potent in vivo efficacy

23-Apr-2025

Keywords

Drug Candidates Sars Cov 2

Article Information

Journal

Science Advances

DOI

10.1126/sciadv.adt7836

Method of Research

Experimental study

Subject of Research

Cells

Article Publication Date

2025-04-23

Article Title

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus- MPro inhibitors with potent in vivo efficacy

Contact Information

Levi Gadye

University of California - San Francisco

levi.gadye@ucsf.edu

Source

This article is based on a news release from University of California - San Francisco. BrightSurf curates and republishes science news from research institutions worldwide; the original release is linked below.

Original Source

https://www.science.org/doi/10.1126/sciadv.adt7836

How to Cite This Article

APA:

University of California - San Francisco. (2025, April 23). Could this molecule be “checkmate” for coronaviruses like SARS- CoV-2?. Brightsurf News. https://www.brightsurf.com/news/1GR45QW8/could-this-molecule-be-checkmate-for-coronaviruses-like-sars-cov-2.html

MLA:

"Could this molecule be “checkmate” for coronaviruses like SARS- CoV-2?." Brightsurf News, Apr. 23 2025, https://www.brightsurf.com/news/1GR45QW8/could-this-molecule-be-checkmate-for-coronaviruses-like-sars-cov-2.html.